Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic β-Cell Mass
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The glucoincretin hormone glucagon-like peptide-1 (GLP-1) increases pancreatic β-cell proliferation and survival through sequential activation of the epidermal growth factor receptor (EGFR), phosphatidylinositol-3 kinase (PI 3-kinase), and Akt. We investigated the role of transcription factor FoxO1 in the proliferative and antiapoptotic actions of GLP-1 in β-cells. GLP-1 inhibited FoxO1 through phosphorylation-dependent nuclear exclusion in pancreatic β (INS832/13) cells. The effect of GLP-1 was suppressed by inhibitors of EGFR (AG1478) and PI 3-kinase (LY294002). In contrast, LY294002 but not AG1478 suppressed insulin-induced FoxO1 phosphorylation. Expression of constitutively nuclear FoxO1 in β-cells prevented the proliferative and antiapoptotic actions of GLP-1 in cultured β-cells and the increase in pancreatic β-cell mass in response to Exendin4 in transgenic mice. Gene expression and chromatin immunoprecipitation assays demonstrated that GLP-1 increases pancreatic and duodenal homeobox gene-1 and Foxa2 expression and inhibits FoxO1 binding to both promoters. We propose that FoxO1 mediates the pleiotropic effects of the glucoincretin hormone on cell proliferation and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A 1-week daily injection of exendin-4 resulted in a twofold increase in β-cell mass (30).”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [30]
Citations
Cites
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356 · cited 1×
“Because FoxO1 controls cell cycle progression (27), we examined whether its inhibition is required for GLP1-dependent -cell proliferation.”
BackgroundSelf-citationHohmeier, H. E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M., & Newgard, C. B. (2000) · Diabetes · doi:10.2337/diabetes.49.3.424 · Cited by 917 · cited 1×
“INS832/13 (22) cells (passage 36–70) were grown in RPMI 1640 medium supplemented with 10 mmol/l HEPES, 10% heat-inactivated FCS, 2 mmol/l L-glutamine, 1 mmol/l sodium pyruvate, 50 mol/l -mercaptoethanol, 100 IU/ml penicillin, and 100 g/ml streptomycin at 37°C in a humidified 5% CO2 atmosphere.”
Glucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.581 · Cited by 897
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652 · cited 1×
“We next transduced cells with a constitutively nuclear FoxO1 mutant (20) or with control -gal adenovirus.”
MethodSelf-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616 · cited 4×
“The mutant transgene carries a single amino acid substitution replacing the main Akt phosphorylation site and is therefore constitutively nuclear (line 305) (19).”
BackgroundMethodSelf-citationHolz IV, G. G., Kiihtreiber, W. M., & Habener, J. F. (1993) · Nature · doi:10.1038/361362a0 · Cited by 594
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W., Wright, C. V. E., White, M. F., Arden, K. C., & Accili, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16857 · Cited by 580 · cited 3×
“We have previously shown that FoxO1 inhibits Pdx1 expression, thereby providing a mechanism by which FoxO1 controls -cell proliferation and insulin secretion (18).”
BackgroundSelf-citation
Cited by
Items 101–192 of 192
Zhang, X., Cao, C., Zheng, F., Liu, C., & Tian, X. (2026) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07670-9 · Cited by 27
Ke, J., Wei, R., Yu, F., Zhang, J., & Hong, T. (2016) · Peptides · doi:10.1016/j.peptides.2016.10.009 · Cited by 27
GLP-1 signaling is required for improvement of glucose tolerance by osteocalcin
Mizokami, A., Mukai, S., Gao, J., Kawakubo‐Yasukochi, T., Otani, T., Takeuchi, H., Jimi, E., & Hirata, M. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0288 · Cited by 27
“On the other hand, GLP-1R signaling inhibits the action of FoxO1 by inducing its nuclear exclusion via activation of phosphatidylinositol 3-kinase (PI3K)–Akt signaling in pancreatic β-cells (Buteau et al. 2006).”
BackgroundThe required beta cell research for improving treatment of type 2 diabetes
Thorens, B. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12096 · Cited by 26
JNK3 Is Required for the Cytoprotective Effect of Exendin 4
Ezanno, H., Pawlowski, V., Abdelli, S., Boutry, R., Gmyr, V., Kerr-Conte, J. A., Bonny, C., Pattou, F. N., & Abderrahmani, A. (2014) · Journal of Diabetes Research · doi:10.1155/2014/814854 · Cited by 25
Kimani, C. N., Reuter, H., Kotzé, S. H., & Muller, C. J. F. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080392 · Cited by 24
Analysis of compensatory β-cell response in mice with combined mutations of Insr and Irs2
Kim, J. J., Kido, Y., Scherer, P. E., White, M. F., & Accili, D. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2006 · Cited by 24
“This is consistent with recent reports indicating that blocking insulin and IGF signaling impairs -cell replication (8, 28, 38).”
ResultSelf-citationThe Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells
Li, Y. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.607 · Cited by 23
Different cell death responses induced by eupomatenoid-5 in MCF-7 and 786-0 tumor cell lines
Longato, G. B., Fiorito, G. F., Costa, D. B. V., Sousa, I. M. D. O., Tinti, S. V., Ruiz, A. L. T. G., de Almeida, S. M. V., Padilha, R. J. R., Foglio, M. A., & de Carvalho, J. E. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.04.002 · Cited by 23
Overexpression of FoxO1 Causes Proliferation of Cultured Pancreatic β Cells Exposed to Low Nutrition
Ai, J., Duan, J., Lv, X., Chen, M., Yang, Q., Sun, H., Li, Q., Xiao, Y., Wang, Y., Zhang, Z., et al. (2009) · Biochemistry · doi:10.1021/bi901414g · Cited by 23
Chen, S., Chen, J., Huang, P., Meng, X., Clayton, S., Shen, J., & Grayburn, P. A. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.038 · Cited by 22
β‐Cells at the crossroads: choosing between insulin granule production and proliferation
Liu, Y., Mziaut, H., Ivanova, A., & Solimena, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01107.x · Cited by 20
Protection of pancreatic β-cells against glucotoxicity by short-term treatment with GLP-1
Park, S.-H., Park, J., Shim, H. M., Na, A., Bae, K.-C., Lim, J.-G., & Song, D. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.139 · Cited by 20
Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice
Cox, A. R., Lam, C. J., Rankin, M. M., Rios, J. S., Chavez, J., Bonnyman, C. W., King, K. B., Wells, R. A., Anthony, D., Tu, J. X., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00027 · Cited by 19
Lucente, D., Bellino, S., & Salvia, A. L. (2025) · Genes · doi:10.3390/genes16111352 · Cited by 18
“It enhances PDX1 expression and nuclear localization, which supports β -cell identity, promotes proliferation, and boosts insulin production—processes essential for maintaining β -cell function and compensating for insulin resistance [21,22].”
Kim, M., & Lee, M. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.1.2 · Cited by 18
Lodato, M., Plaisance, V., Pawlowski, V., Kwapich, M., Barras, A., Buissart, E., Dalle, S., Szunerits, S., Vicogne, J., Boukherroub, R., et al. (2023) · Cells · doi:10.3390/cells12060940 · Cited by 17
Zheng, W., Li, L., & Li, H. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114817 · Cited by 16
Role of SIRT-1 as a Target for Treatment and Prevention of Diabetic Nephropathy: A Review
Kumari, A., Sodum, N., Ravichandiran, V., & Kumar, N. (2023) · Current Molecular Pharmacology · doi:10.2174/1874467216666230109140134 · Cited by 16
Bohman, S., Waern, I., Andersson, A., & King, A. (2007) · Cell Transplantation · doi:10.3727/000000007783464452 · Cited by 16
“The large immune cells are excluded whereas small mole- and induces genes that are implicated in beta cell survival (2,3,7,24).”
BackgroundPaglialunga, S., Simnett, G., Robson, H., Hoang, M., Pillai, R., Arkell, A. M., Simpson, J. A., Bonen, A., Huising, M. O., Joseph, J. W., et al. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0585 · Cited by 16
“(B) WT and KO rats express similar levels of AS160, Akt2 and GLUT4 in muscle.”
BackgroundInfluentialGLP-1 signaling and the regulation of pancreatic β-cells mass/function
Buteau, J. (2011) · Avances en Diabetología · doi:10.1016/s1134-3230(11)70002-3 · Cited by 14
Self-citationLinnemann, A. K., & Davis, D. B. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12465 · Cited by 14
Liu, J., Hu, Y., Xu, Y., Jia, Y., Li, M., & Wang, G. (2017) · International Journal of Endocrinology · doi:10.1155/2017/9401606 · Cited by 13
“Animal studies have demonstrated that GLP-1 promotes the proliferation of β-cells and inhibits their apoptosis [29, 30].”
BackgroundShah, M. A., Haris, M. N., Faheem, H. I., Hamid, A., Yousaf, R., Rasul, A., Shah, G. M., Khalil, A. A. K., Wahab, A., Khan, H. Z., et al. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220628123224 · Cited by 14
Molecular Basis of cAMP Signaling in Pancreatic β Cells
Holz, G. G., Chepurny, O. G., Leech, C. A., Song, W., & Hussain, M. A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_25 · Cited by 12
“2011), and transcription factor FoxO1 (Buteau et al. 2006).”
Korkmaz, Y., & Dik, B. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12975 · Cited by 12
“Exenatide provides improvements in β -cell function by the Akt/PI3K/FoxO1 pathways and mitogen-activated protein kinase (MAPK) mediate [80, 81].”
Protective Role of Glucagon-Like Peptide-1 Against High-Glucose-Induced Endothelial Oxidative Damage
Guo, L., Qiao, Y., Zhang, L., & Pan, Q. (2015) · Medicine · doi:10.1097/md.0000000000002055 · Cited by 11
“D-glucose, GLP-1(7-36), MTT, and collagenase I were purchased from Sigma Aldrich (Shanghai, China).”
MethodWang, T., Zhang, P., Zhang, X., Cao, T., Zheng, C.-Z., & Yu, B. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.08.500 · Cited by 11
Greco, M., Munir, A., Musarò, D., Coppola, C., & Maffia, M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1244022 · Cited by 10
“Subsequently, several downstream actors such as GSK3-β , FoxO1, NF-κ B and Nrf2 exert cytoprotective effects (Buteau et al., 2006; Dai et al., 2013; Park et al., 2018; Costantino and Paneni, 2019; Li et al., 2020).”
BackgroundForkhead box O1 promotes INS-1 cell apoptosis by reducing the expression of CD24
Ma, Y., Wang, X., Peng, Y., & Ding, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4896 · Cited by 10
“Proteins were extracted from the pancreatic islets as previously described (11), concentration was determined using the Bradford assay and equal quantities of protein (20 µg) were resolved by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis.”
Protective Role of PPARdelta in Lipoapoptosis of Pancreatic β Cells
Yang, Y., Ren, J., Tong, Y., Hu, X., Lv, Q., & Tong, N. (2016) · Lipids · doi:10.1007/s11745-016-4190-5 · Cited by 10
Aulinger, B., & D'Alessio, D. (2007) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328013e79e · Cited by 8
[Transcription factors in the adult beta cell].
Lazo-de-la-Vega-Monroy, M.-L., & Fernández‐Mejía, C. (2009) · PubMed · Cited by 8
Protein restriction during pregnancy impairs intra-islet GLP-1 and the expansion of β-cell mass
de Arruda, E. H. P., da Silva, G. L. V., da Rosa-Santos, C. A., Arantes, V. C., Reis, M. A. D. B., Colodel, É. M., de Moura, E. G., Lisboa, P. C., Carneiro, E. M., Damazo, A. S., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110977 · Cited by 8
The PI3K/Akt1-FoxO1 Translocation Pathway Mediates EXf Effects on NIT-1 Cell Survival
Hou, G., Li, C.-N., Huan, Y., Liu, S., Liu, Q., Liu, M., & Shen, Z. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-117048 · Cited by 8
Pancreatic β‐cell turnover in health and disease
Alcibahy, Y., Darwish, R., Butler, A. E., & Moin, A. S. M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70191 · Cited by 7
“67 In human pancreatic islets, a defined subset of α -cells expresses PC1/3 (PCSK1), processes proglucagon to GLP-1, and contains peptide confirmed by immunoblotting and Matrix Assisted Laser Desorption/Ionization with Time of Flight analysis (MALDI-TOF), establishing a bona fide intra-islet source…”
Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence
Dong, W., Zhang, H., Mu, S., Shi, S., Zhang, J., & Xu, K. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70131 · Cited by 7
“54 Remodeling the balance of lipid metabolism GLP-1 and its analogs exert a dual regulatory effect on lipid metabolism by inhibiting lipid synthesis and promoting lipolysis.”
Development of a red fluorescent protein-based cGMP indicator applicable for live-cell imaging
Takizawa, M., Osuga, Y., Ishida, R., Mita, M., Harada, K., Ueda, H., Kitaguchi, T., & Tsuboi, T. (2022) · Communications Biology · doi:10.1038/s42003-022-03790-2 · Cited by 7
Baden, M. Y., Fukui, K., Hosokawa, Y., Iwahashi, H., Imagawa, A., & Shimomura, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144606 · Cited by 7
Wu, Y.-J., Wu, Y., Fang, Z., Chen, M., Wang, Y., Wu, C.-Y., & Lv, M.-A. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/5356825 · Cited by 7
Growth Factor Mediated Regulation of Beta Cell Survival
Vasavada, R. C. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010078 · Cited by 6
“GLP-1 inhibited FoxO1 through phosphorylation-dependent nuclear exclusion, which was dependent on EGF receptor and PI3K activation, in INS832/13 cells [60].”
BackgroundEgr-1 transactivates WNT5A gene expression to inhibit glucose-induced β-cell proliferation
Wu, X., Li, Z., Chen, K., Yin, P., Zheng, L., Sun, S., & Chen, X. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.07.006 · Cited by 6
Wieland, F. C., Sthijns, M. M. J. P. E., Geuens, T., van Blitterswijk, C., & LaPointe, V. L. S. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.729057 · Cited by 5
Incretins and Regulation of Insulin Secretion
Nauck, M. A., & Meier, J. J. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_17 · Cited by 4
Gandhi, V. D., Palikhe, N. S., Hamza, S. M., Dyck, J. R. B., Buteau, J., & Vliagoftis, H. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.040 · Cited by 4
Self-citationBarakat, G. M., Assi, G., Khalil, H., & Khatib, S. E. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998287178240403055901 · Cited by 3
FoxO proteins in pancreatic β-cells as potential therapeutic targets in diabetes
Glauser, D. A., & Schlegel, W. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.2.175 · Cited by 3
Effects of gastric bypass on FoxO1 expression in the liver and pancreas of diabetic rats
Chen, Z., Meng, C., Liu, J., Zhang, J., Kou, Y., Zhang, L., & Wang, Z. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1044010 · Cited by 3
“This process, in turn, leads to FoxO1 phosphorylation and permits pho-FoxO1 to translocate from the nucleus to the cytoplasm (23,24).”
BackgroundIncretin Therapy and Beta Cell Function
Goundan, P. N., UNDERWOOD, P. C., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.006 · Cited by 2
Damayanti, D. S., Nurdiana, N., KUSUMA, M. C., & Soeatmadji, D. W. (2019) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2019.v11s6.33549 · Cited by 2
“The phosphorylation of FoxO1 causes the proliferation of pancreatic β-cells [27, 28].”
Backgroundda Rosa-Santos, C. A., Rodrigues, P. D. C., Silva, L. R., Arantes, V. C., Reis, M. A. D. B., Colodel, É. M., Damazo, A. S., de Moura, E. G., Carneiro, E. M., & Latorraca, M. Q. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02192-6 · Cited by 2
Maximizing endogenous β-cell regeneration
Crutchlow, M. F., & Stoffers, D. A. (2007) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328012b281 · Cited by 2
The Regulation of Mammalian Target of Rapamycin
Xie, J. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
Jetton, T. L., Gupta, D., & Peshavaria, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-256-8_3 · Cited by 1
FOXO1 transcription factor modulates airway epithelial responses to viral infection
Daniel, N. M., Mann‐Nüttel, R., Palikhe, N. S., López-Orozco, J., Hobman, T. C., Forsythe, P., & Vliagoftis, H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0345169 · Cited by 1
“As a result, CA-FOXO1 remains transcriptionally active in the nucleus independent of upstream PI3K–Akt signaling [15].”
Molecular Biology of Gluco-Incretin Function
Klinger, S., & Thorens, B. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_16 · Cited by 1
Molecular Basis of cAMP Signaling in Pancreatic Beta Cells
Holz, G. G., Chepurny, O. G., Leech, C. A., Song, W., & Hussain, M. A. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_25-3 · Cited by 1
Nigris, V. D. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Lim, G. E. (2010) · TSpace (University of Toronto) · Cited by 1
Liboz, A. (2022) · theses.fr (ABES) · doi:10.70675/9abd3277zd4c4z48f5za637z73aeb8a7a807 · Cited by 1
Mostafa, N. M. E.-S. B. E.-D. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Cellular aging in cardiovascular diseases
Oeseburg, H. (2010) · University of Groningen research database (University of Groningen / Centre for Information Technology)
GLP‐1 Biology, Signaling Mechanisms, Physiology, and Clinical Studies
Burcelin, R., Cabou, C., Magnan, C., & Gourdy, P. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch11
Grabmaier, U. (2011) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.13040
Forkhead-box-O1 locus y marcadores metabólicos en los ancianos: estudio de asociación
Paroni, G., Addante, F., Seripa, D., Panza, F., Copetti, M., Fontana, L., & Pilotto, A. (2012) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2012.06.004
VandenBerg, P. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.08.007
Saifudin, N. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb10.2220
“Applications using β-gal as a reporter molecule include transcription studies (Buteau et al., 2006); enhancer, promoter and gene trap applications (Watt et al., 2001) as well as fusion protein (Rönnmark et al., 2003).”
BackgroundMethodWidenmaier, S. B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071070
Advances on Molecular Mechanism of Glucagon-like Peptide-1 Induced Pancreatic β-Cell Protection
Miao, X., Liu, Y., & Li, C. (2013) · ACTA AGRONOMICA SINICA · doi:10.3724/sp.j.1206.2013.00041
Merchant, C. E. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0105089
“…up-regulation of Bcl-2 and Bcl-xL expression via PKA-and PI3K-dependent pathways (Hui et al., 2003), the up-regulation of Pdx1 following FoxO1 nuclear exclusion via the EGFR- PI3K-Akt/PKB pathway (Buteau et al., 2006) and inhibition of the cytokine-activated JNK pathway (Ferdaoussi et al., 2008).”
BackgroundInvestigation into glucagon like peptide-1 signalling in pancreatic [beta}-cells
Moore, C. E. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Funktionelle Bedeutung von Somatostatin für die pankreatischen Beta-Zellen und Adipozyten
Hofmann, F. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4703
Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis
Flock, G. B. (2012) · TSpace (University of Toronto)
Franco, M. T. B. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo
Zadeh‐Tahmasebi, M. (2015) · TSpace (University of Toronto)
Arıkan, F. B. (2017) · DSpace - FIRAT (Fırat University)
The role of c-Kit and insulin receptor tyrosine kinases in beta cell function and insulin secretion
Oakie, A. (2019) · Scholarship@Western (Western University)
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32802e6d87
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282c3a898
Wang, H., Lazarovici, P., & Zheng, W. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101601
Wang, H., Lazarovici, P., & Zheng, W. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101601-1
Current literature in diabetes
(2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.720
MicroRNAs and diabetes mellitus
Jankauskas, S. S., Gambardella, J., Kansakar, U., Wilson, S. M., Mone, P., Varzideh, F., Donkor, K., Eacobacci, M., Adebayo, A., Morelli, M. B., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00001-7
Neue Ansätze zur Regeneration der insulinproduzierenden β-Zelle
Schlüssel, E., & Lickert, H. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00945-x
Rial, S. A. (2020) · Archipel (Université du Québec à Montréal)
Incretins: From Gene Expression to Secretion and Action of GLP-1 and GIP
Lobato, C. B., & Holst, J. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00004-4
Adhikari, S., Carlyle, B. C., & de Wet, H. (2026) · The Journal of Precision Medicine Health and Disease · doi:10.1016/j.premed.2026.100057
The incidence of neoplasms in the treatment with GLP-1R agonists
Santos, M. A. M. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Metadata
- Authors
- Buteau, J., Spatz, M. L., & Accili, D.
- Affiliations
- Columbia University Irving Medical Center (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-05-01
- Volume
- 55
- Issue
- 5
- Pages
- 1190-1196
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2122464768
- Cited by
- 178
- References
- 38
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 7 · 2016: 12 · 2015: 11 · 2014: 13 · 2013: 10 · 2012: 15
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-64819, R01DK064819)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- FOXO1, glucagon-like peptide-1, beta-cell mass, beta-cell proliferation, beta-cell apoptosis, nuclear exclusion, EGFR signaling, PI3K/Akt signaling, exendin-4, PDX1, FOXA2, transcriptional regulation, insulin
- MeSH terms
- Forkhead Box Protein O1, Animals, Cell Division, Cell Line, Cell Survival, Glucagon-Like Peptides, Glucagon, Glucose, Insulin, Islets of Langerhans, Mice, Transgenic, Peptide Fragments, Green Fluorescent Proteins, Mice, Forkhead Transcription Factors, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.